Investor Information

Focusing on Quality. Delivering Innovation. Transforming Patient Care at the Bedside.

At Avancen, we’re innovators in improving patient care at the bedside through the ongoing success of the wireless Medication on Demand (MOD®), the “world’s first” oral PCA (Patient Controlled Analgesia) device. Approved by the FDA, the MOD® device is currently marketed and sold to hospitals and skilled nursing facilities around the country, and is being integrated into the top Electronic Medical Record systems. In addition to our current hospital clients, clinical trials are also currently underway in well-known and respected US hospitals.

As an investor-owned company, we extend a thank you to all of our  investors who stand beside us and support our mission of providing the tools, talent and technology to benefit our hospital and healthcare customers and the patients they serve. If you are interested in investing in Avancen MOD Corporation, email us below:

Attention: Investor Relations


Avancen MOD Corporation

1156 Bowman Road, Suite 200

Mount Pleasant, SC 29464


or call us at: